5 Stocks Under $30 to Buy Today According to Billionaire Steven Cohen
In this piece, we will look at the ten stocks under $30 to buy today according to billionaire Steven Cohen.
Protagonist Therapeutics Inc (PTGX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,775,900 | $86,845,700 | 3.17% | |
| 2. | Farallon Capital Thomas Steyer | 2,615,014 | $60,145,322 | -29% | 0.34% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 2,558,000 | $58,834,000 | +234% | 0.13% |
| 4. | Kynam Capital Derrick Tang | 1,375,000 | $31,625,000 | +164% | 4.08% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,366,080 | $31,419,840 | -7% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.70 | 12,000 | Director | 15,310 | 2020-03-12 | Filing | |
| $5.70 | 8,000 | Director | 8,000 | 2019-12-03 | Filing | |
| $5.13 | 30,000 | Officer | 49,500 | 2019-12-03 | Filing | |
| $5.09 | 562 | Officer | 1,175 | 2019-12-03 | Filing | |
| $5.10 | 613 | Officer | 613 | 2019-12-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $32.14 | 15,000 | Officer, Director | 477,158 | 2021-12-21 | Filing | |
| $47.56 | 14,779 | Officer | 58,254 | 2021-08-17 | Filing | |
| $25.09 | 3,700 | Director | 0 | 2021-02-11 | Filing | |
| $26.04 | 400 | Director | 0 | 2021-02-10 | Filing | |
| $25.42 | 4,300 | Director | 400 | 2021-02-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 4,600,799 | $105,818,377 | 2.2% | |
| 2. | 4,402,217 | $101,250,991 | 0% | |
| 3. | 3,241,293 | $74,549,739 | 0% | |
| 4. | 2,449,183 | $56,331,209 | 18.32% | |
| 5. | 2,413,701 | $55,514,803 | 0% |
News See All
These 5 Stocks Are Crashing Today
In this article, we take a look at five stocks that are crashing today.
Protagonist Therapeutics, Inc. (PTGX) Fell Out Of Favor With Hedge Funds
In this article we will check out the progression of hedge fund sentiment towards Protagonist Therapeutics, Inc. (NASDAQ:PTGX) and determine whether it is a good investment right now.
5 Small-Cap Stocks to Buy According to Billionaire Steve Cohen
In this article, we discuss the 5 small-cap stocks to buy according to billionaire Steve Cohen.
5 Best Biotech Stocks to Buy According to Mark Lampert's Biotechnology Value Fund
In this article, we discuss the 5 best biotech stocks to buy according to Mark Lampert.
5 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
Below is the list of 5 pharma stocks to buy according to Mark Lampert’s Biotechnology Value Fund.
Hedge Funds Are Crazy About Protagonist Therapeutics, Inc. (PTGX)
At Insider Monkey, we pore over the filings of nearly 873 top investment firms every quarter, a process we have now completed for the latest reporting period.
Protagonist Therapeutics, Inc. (PTGX) Fell Out Of Favor With Hedge Funds
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Is PTGX Stock A Buy or Sell?
In this article you are going to find out whether hedge funds think Protagonist Therapeutics, Inc. (NASDAQ:PTGX) is a good investment right now.
Is PTGX A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Billionaire Hedge Funds
